JP2013227218A5 - - Google Patents

Download PDF

Info

Publication number
JP2013227218A5
JP2013227218A5 JP2013120309A JP2013120309A JP2013227218A5 JP 2013227218 A5 JP2013227218 A5 JP 2013227218A5 JP 2013120309 A JP2013120309 A JP 2013120309A JP 2013120309 A JP2013120309 A JP 2013120309A JP 2013227218 A5 JP2013227218 A5 JP 2013227218A5
Authority
JP
Japan
Prior art keywords
composition
platinum
trans
cyclohexanediamine
dihydroxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013120309A
Other languages
English (en)
Japanese (ja)
Other versions
JP5647300B2 (ja
JP2013227218A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013227218A publication Critical patent/JP2013227218A/ja
Publication of JP2013227218A5 publication Critical patent/JP2013227218A5/ja
Application granted granted Critical
Publication of JP5647300B2 publication Critical patent/JP5647300B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013120309A 2007-08-06 2013-06-07 ホスファプラチン、ならびにシスプラチンおよびカルボプラチンに対し耐性を有する癌の治療におけるその使用 Active JP5647300B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US95412607P 2007-08-06 2007-08-06
US60/954,126 2007-08-06
US97392607P 2007-09-20 2007-09-20
US60/973,926 2007-09-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010520294A Division JP5385274B2 (ja) 2007-08-06 2008-08-06 ホスファプラチン、ならびにシスプラチンおよびカルボプラチンに対し耐性を有する癌の治療におけるその使用

Publications (3)

Publication Number Publication Date
JP2013227218A JP2013227218A (ja) 2013-11-07
JP2013227218A5 true JP2013227218A5 (https=) 2013-12-19
JP5647300B2 JP5647300B2 (ja) 2014-12-24

Family

ID=40342030

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010520294A Active JP5385274B2 (ja) 2007-08-06 2008-08-06 ホスファプラチン、ならびにシスプラチンおよびカルボプラチンに対し耐性を有する癌の治療におけるその使用
JP2013120309A Active JP5647300B2 (ja) 2007-08-06 2013-06-07 ホスファプラチン、ならびにシスプラチンおよびカルボプラチンに対し耐性を有する癌の治療におけるその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010520294A Active JP5385274B2 (ja) 2007-08-06 2008-08-06 ホスファプラチン、ならびにシスプラチンおよびカルボプラチンに対し耐性を有する癌の治療におけるその使用

Country Status (12)

Country Link
US (4) US7700649B2 (https=)
EP (2) EP2668949A1 (https=)
JP (2) JP5385274B2 (https=)
CN (1) CN101801369B (https=)
CY (1) CY1115504T1 (https=)
DK (1) DK2173337T3 (https=)
ES (1) ES2495743T3 (https=)
HR (1) HRP20140808T1 (https=)
PL (1) PL2173337T3 (https=)
PT (1) PT2173337E (https=)
SI (1) SI2173337T1 (https=)
WO (2) WO2009021081A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2495743T3 (es) * 2007-08-06 2014-09-17 Ohio University Fosfaplatinos y su uso en el tratamiento de cánceres resistentes a cisplatino y carboplatino
CN108210516A (zh) * 2010-06-04 2018-06-29 俄亥俄大学 磷铂及其在治疗癌症中的用途
US20130236568A1 (en) 2011-01-12 2013-09-12 Ohio University Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
EP2729526B1 (en) 2011-07-08 2017-10-04 Dow Global Technologies LLC Polyethylene blend composition suitable for blown film, method of producing the same, and films made therefrom
JP6027619B2 (ja) 2011-10-05 2016-11-16 ラシンドラ・エヌ・ボーズ ホスファプラチン系抗腫瘍剤の大規模調製のための効率的プロセス
WO2013052839A1 (en) 2011-10-05 2013-04-11 Bose Rathindra N Efficient processes for large scale preparation of phosphaplatins antitumor agents
MX365635B (es) 2011-10-20 2019-06-10 Nerium Biotechnology Inc Combinacion terapeutica para el tratamiento de cancer.
LT2855496T (lt) * 2012-05-24 2017-04-10 Phosplatin Therapeutics Llc Fosfaplatinos junginių sintezės ir gryninimo būdai ir jų panaudojimas
EP2958568B1 (en) * 2013-02-22 2020-03-04 University Of Houston Phosphaplatins as neuroprotective agents
WO2015127037A1 (en) * 2014-02-19 2015-08-27 University Of Houston System Compositions and methods for the treatment of neurodegenerative diseases
MX370673B (es) 2014-06-11 2019-12-19 Univ Texas Conjugados y composiciones de texafirina-pt (iv) para su uso para superar la resistencia del platino.
EP3397642A1 (en) 2015-12-30 2018-11-07 Atilim Universitesi Dna targeted mono and heterodinuclear complexes
TWI791008B (zh) 2017-01-06 2023-02-01 美商弗斯普萊汀治療股份有限公司 作為供骨癌或血癌治療用之治療劑的磷酸鉑(phosphaplatin)化合物
JP7381083B2 (ja) 2017-09-08 2023-11-15 フォスプラティン テラピューティクス インコーポレイテッド 免疫調節剤としてのホスファプラチン化合物およびその治療的使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291027A (en) 1979-03-07 1981-09-22 Engelhard Minerals & Chemicals Corp. Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
US4234500A (en) * 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
CA2017739A1 (en) * 1989-07-18 1991-01-18 Engelhard Corporation Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
EP1644388A2 (en) * 2003-06-27 2006-04-12 ODANI, Akira Bisphosphonate complexes
EP2177525A1 (en) * 2007-07-06 2010-04-21 TMRC Co., Ltd. Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound
ES2495743T3 (es) * 2007-08-06 2014-09-17 Ohio University Fosfaplatinos y su uso en el tratamiento de cánceres resistentes a cisplatino y carboplatino

Similar Documents

Publication Publication Date Title
JP2013227218A5 (https=)
JP2014534220A5 (https=)
ES2495743T3 (es) Fosfaplatinos y su uso en el tratamiento de cánceres resistentes a cisplatino y carboplatino
JP2016501882A5 (https=)
JP2019513764A5 (https=)
JP2008509166A5 (https=)
JP2008522981A5 (https=)
JP2016505595A5 (https=)
JP2016153410A5 (https=)
JP2014508753A5 (https=)
JP2014524888A5 (https=)
JP2010523476A5 (https=)
JP2013518036A5 (https=)
JP2012512907A5 (https=)
JP2015508103A5 (https=)
JP5860872B2 (ja) ホスファプラチン、及び癌治療のためのそれらの使用
JP2018135343A5 (https=)
JP2019525899A5 (https=)
RU2015127827A (ru) Производные бензилиденгуанидина и их терапевтическое применение для лечения заболеваний, связанных с неправильным сворачиванием белков
JP2006519852A5 (https=)
JP2015051983A5 (https=)
CN105566653B (zh) 一种两性羧酸镧金属有机骨架及其合成方法和应用
JP2015063755A5 (https=)
JP2011016798A5 (https=)
RU2014113399A (ru) Новый режим приема n-гидрокси-4-{2-[3-(n, n-диметиламинометил)бензофуран-2-илкарбониламино]этокси}бензамида